Comments on: Thoughts on Leica Buying Aperio https://tissuepathology.com/2012/08/23/leicabuysaperiopart1/ Educational and informative Thu, 13 Oct 2016 06:43:09 +0000 hourly 1 By: Roderick Neeon https://tissuepathology.com/2012/08/23/leicabuysaperiopart1/#comment-148242 Thu, 13 Oct 2016 06:43:09 +0000 http://tissuepathology.org/posts/pathology-news/leicabuysaperiopart1/#comment-148242 My business partners required MD Uniform Consultation Referral Form some time ago and came across a web service that has lots of sample forms . If others have been needing MD Uniform Consultation Referral Form too , here’s https://goo.gl/24dtjn

]]> By: S https://tissuepathology.com/2012/08/23/leicabuysaperiopart1/#comment-60063 Mon, 20 Oct 2014 08:28:19 +0000 http://tissuepathology.org/posts/pathology-news/leicabuysaperiopart1/#comment-60063 Any thoughts on how this acquisition has affected Aperio’s SlidePath solution over the past couple of years?

It appears to have increasingly moved towards a ‘proprietary’ or ‘locked’ attitude and institutions that use scanners that are from multiple companies (e.g. Zeiss, Hamamatsu, etc.) are unable to integrate those outputs with Digital SlideBox or Digital Image Hub it seems.

Hence I would argue that in the current state they are only promoting customers to stick with Aperio products and in doing so marginalising their customer base – leaving the impression that Aperio being owned by Leica care more about cashflow than about customer requirements in the ePathology/Virtual Microscopy field.

Do you have any thoughts around this?

]]>